The latest announcement is out from QuidelOrtho (QDEL).
QuidelOrtho Corporation has announced the appointment of Brian J. Blaser as its new President and CEO, starting May 6, 2024, with an additional role as a director of the company. Blaser brings a wealth of experience from his previous tenure at Abbott Laboratories and other industry-leading firms. His compensation package includes a $1 million base salary, significant bonus opportunities, and substantial equity grants tied to performance metrics. Blaser’s leadership is anticipated to steer the company towards new heights in the diagnostics sector.
For detailed information about QDEL stock, go to TipRanks’ Stock Analysis page.
